228 related articles for article (PubMed ID: 28545305)
1. Clostridium difficile toxins A and B: Receptors, pores, and translocation into cells.
Orrell KE; Zhang Z; Sugiman-Marangos SN; Melnyk RA
Crit Rev Biochem Mol Biol; 2017 Aug; 52(4):461-473. PubMed ID: 28545305
[TBL] [Abstract][Full Text] [Related]
2. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
[TBL] [Abstract][Full Text] [Related]
3. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
4. Receptors and Binding Structures for Clostridium difficile Toxins A and B.
Gerhard R
Curr Top Microbiol Immunol; 2017; 406():79-96. PubMed ID: 27380268
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
7. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
8. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
9. Chloroquine derivatives block the translocation pores and inhibit cellular entry of Clostridium botulinum C2 toxin and Bacillus anthracis lethal toxin.
Kreidler AM; Benz R; Barth H
Arch Toxicol; 2017 Mar; 91(3):1431-1445. PubMed ID: 27106023
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
11. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
12. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
[No Abstract] [Full Text] [Related]
13. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate
Larabee JL; Bland SJ; Hunt JJ; Ballard JD
mBio; 2017 May; 8(3):. PubMed ID: 28512094
[No Abstract] [Full Text] [Related]
14. Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain.
Gerhard R; Frenzel E; Goy S; Olling A
J Med Microbiol; 2013 Sep; 62(Pt 9):1414-1422. PubMed ID: 23558138
[TBL] [Abstract][Full Text] [Related]
15. Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore.
Zhang Z; Park M; Tam J; Auger A; Beilhartz GL; Lacy DB; Melnyk RA
Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3721-6. PubMed ID: 24567384
[TBL] [Abstract][Full Text] [Related]
16. The Compound U18666A Inhibits the Intoxication of Cells by
Papatheodorou P; Kindig S; Badilla-Lobo A; Fischer S; Durgun E; Thuraisingam T; Witte A; Song S; Aktories K; Chaves-Olarte E; Rodríguez C; Barth H
Front Microbiol; 2021; 12():784856. PubMed ID: 34912322
[TBL] [Abstract][Full Text] [Related]
17. Binding and entry of Clostridium difficile toxin B is mediated by multiple domains.
Manse JS; Baldwin MR
FEBS Lett; 2015 Dec; 589(24 Pt B):3945-51. PubMed ID: 26602083
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.
Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K
Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
